Alpha Profiles · Company Profile

Edgewise Therapeutics, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/edgewise-therapeutics-inc

Entity: Public listing published
Primary listing: NASDAQ: EWTX
Verification: Partially verified
Last reviewed: 2026-09-06T06:20:25.751031+00:00

Overview

Alpha's canonical identity and public leadership record for Edgewise Therapeutics, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

7 public records

Alan Russell

Chief Scientific Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-047688Apr 23, 2026

Behrad Derakhshan

Chief Operating Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-047688Apr 23, 2026

Joanne M. Donovan

Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-047688Apr 23, 2026

John R. Moore

General Counsel

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-047688Apr 23, 2026

Kevin Koch

President and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-047688Apr 23, 2026

Michael P. Nofi

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-047688Apr 23, 2026

Not provided

General Counsel

State: confirmed
Effective: From Feb 26, 2026
Confidence: 94%
Evidence: EWTX 10-K executive officersFeb 26, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 6, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.